Following a study whose data revealed an unusually high failure rate of 43 percent for certain types of metal-on-metal hip implants, the UK has prohibited the use of these types…
In the United Kingdom, the Department of Health and the Medicines and Healthcare Products Regulatory Agency (MHRA) have been collaborating on a safety review of transvaginal mesh. Their collaborative effort…
An article recently published by UK news organization the Daily Mail describes the country’s increased efforts in requiring physicians to adequately warn patients of the risks of using certain kinds…
During the annual American Urological Association meeting, urology researchers presented data from two recently completed studies on the surgical removal of transvaginal mesh. The studies produced varied results. One study…
The latest news relating to transvaginal mesh lawsuits involves a new court document filed in a federal court in West Virginia. The court document relates to the rescheduling of forthcoming…
Sales are down for testosterone replacement therapy drugs, such as the two most popular testosterone gels, Androgel and Axiron. After a huge spike in 2013 in prescriptions and sales, 2014…
The news has been overrun of late by research connecting testosterone replacement therapy with poor cardiovascular health. Though testosterone gel’s effects on heart health continue to be a major concern,…
The New England Journal of Medicine (NEJM) recently conducted a community poll on testosterone gel safety that concluded on December 2, 2014. The purpose of the poll was to get…
Testosterone gel lawsuits continue to mount against pharmaceutical companies, including AbbVie, the company behind Androgel, and Eli Lilly & Co, the manufacturer of Axiron. These lawsuits cite testosterone gel injuries….
In what is an unfortunate distraction in the Johnson & Johnson and Ethicon multidistrict litigation (MDL) in West Virginia, news of telephone scammers contacting women about filing transvaginal mesh lawsuits…